Link to Dr. Gary Kay’s Webinar: “Evaluating Your Compound’s Impact on Driving”
Check out the recording of Dr. Gary Kay’s recent webinar, “Evaluating Your Compound’s Impact on Driving.” (Skip to the three-minute mark for the beginning of the webinar.)
In this informative webinar, Cognitive Research Corporation‘s President, Gary Kay, Ph.D., assists you in understanding and implementing FDA requirements for evaluating your compound’s impact on driving.
An expert in driving simulation studies, Dr. Kay has served as the Principal Investigator on single and multi-center clinical drug trials investigating the effects of medications on cognition, mood, and psychomotor performance. Dr. Kay is an Associate Professor of Neurology at Georgetown University. He received his Ph.D. in psychology (Clinical Neuropsychology Specialty Program) at the University of Memphis (formerly Memphis State University). Dr. Kay has been an invited speaker at professional meetings across the United States and around the world.
For a 1:1 conversation with Dr. Kay about your compound, contact Bobbie Theodore, Alliance Director, at email@example.com or (916) 939-6696.